Intellia Therapeutics's banner
Intellia Therapeutics's profile picture

Intellia Therapeutics

@intelliatx • 12,206 subscribers

We're a #GeneEditing company, developing novel, potentially curative therapeutics leveraging #CRISPR-based technologies. Guidelines: https://t.co/u2gHl9Tmgr

Shorts

#ATTR News: Intellia doses the first patient in its Phase 3 MAGNITUDE study of NTLA-2001 for the potential treatment of #transthyretinamyloidosis with cardiomyopathy: #GeneEditing #CRISPR

#ATTR News: Intellia doses the first patient in its Phase 3 MAGNITUDE study of NTLA-2001 for the potential treatment of #transthyretinamyloidosis with cardiomyopathy: #GeneEditing #CRISPR

26,655 просмотров

#ATTR News: $NTLA announces positive new clinical data from the ongoing Phase 1 trial of nexiguran ziclumeran (nex-z) in patients with #ATTR amyloidosis with cardiomyopathy. Full details here: Join us at 12 p.m. ET for a webcast discussing the data, as well as an update from the ongoing Phase 1 polyneuropathy cohort. #CRISPR #GeneEditing

#ATTR News: $NTLA announces positive new clinical data from the ongoing Phase 1 trial of nexiguran ziclumeran (nex-z) in patients with #ATTR amyloidosis with cardiomyopathy. Full details here: Join us at 12 p.m. ET for a webcast discussing the data, as well as an update from the ongoing Phase 1 polyneuropathy cohort. #CRISPR #GeneEditing

19,272 просмотров

NEWS: $NTLA receives authorization by the MHRAgovuk to initiate a Phase 1/2 of NTLA-3001 for the treatment of #alpha1 antitrypsin deficiency-associated lung disease. This is Intellia's first wholly owned in vivo gene insertion program. #CRISPR #AATD

NEWS: $NTLA receives authorization by the MHRAgovuk to initiate a Phase 1/2 of NTLA-3001 for the treatment of #alpha1 antitrypsin deficiency-associated lung disease. This is Intellia's first wholly owned in vivo gene insertion program. #CRISPR #AATD

19,065 просмотров

$NTLA announces recent company progress and second quarter financial results. Read the press release:

$NTLA announces recent company progress and second quarter financial results. Read the press release:

10,146 просмотров

Congratulations to Vertex Pharmaceuticals and CRISPR Therapeutics for achieving the first-ever MHRAgovuk approval of a #CRISPR therapy. This historic milestone is paving the way for the future of #geneediting.

Congratulations to Vertex Pharmaceuticals and CRISPR Therapeutics for achieving the first-ever MHRAgovuk approval of a #CRISPR therapy. This historic milestone is paving the way for the future of #geneediting.

16,935 просмотров

Intellia announces positive long-term data from its ongoing Phase 1 study of NTLA-2002 for #hereditaryangioedema at EAACI 2024 Congress. Full details here: #HAE #CRISPR #geneediting

Intellia announces positive long-term data from its ongoing Phase 1 study of NTLA-2002 for #hereditaryangioedema at EAACI 2024 Congress. Full details here: #HAE #CRISPR #geneediting

13,393 просмотров

Videos

LIVE
1.2k

Anya Rossi

sweetdream.ai

SweetDream.aiSponsored•Livecam
Streaming Now

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

HD live stream
Exclusive private shows
1.2k viewers online

Free preview available • Premium content

Great way to wrap up a historic week! We’re honored to light up the iconic Nasdaq Tower in Times Square celebrating Intellia's recent #CRISPR milestone. A big thanks to Nasdaq for recognizing our recent HAELO topline data, a first ever for in vivo #geneediting.
0:30
intelliatx's profile picture

Great way to wrap up a historic week! We’re honored to light up the iconic Nasdaq Tower in Times Square celebrating Intellia's recent #CRISPR milestone. A big thanks to Nasdaq for recognizing our recent HAELO topline data, a first ever for in vivo #geneediting.

Intellia Therapeutics

14,508 просмотров • 3 месяцев назад

Congratulations to Vertex Pharmaceuticals and CRISPR Therapeutics for achieving the first-ever MHRAgovuk approval of a #CRISPR therapy. This historic milestone is paving the way for the future of #geneediting.
0:20
intelliatx's profile picture

Congratulations to Vertex Pharmaceuticals and CRISPR Therapeutics for achieving the first-ever MHRAgovuk approval of a #CRISPR therapy. This historic milestone is paving the way for the future of #geneediting.

Intellia Therapeutics

16,935 просмотров • 2 лет назад

Больше нет контента для загрузки